Butterbur (Petasites hybridus) — Hermetica Encyclopedia
Herbs (Global Traditional) · European

Butterbur (Petasites hybridus)

Provisional Strong Scorebotanical

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Butterbur (Petasites hybridus) is a perennial plant whose PA-free root extracts contain petasins as primary bioactive compounds. These compounds inhibit NF-κB signaling pathways to provide anti-inflammatory and spasmolytic effects.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryHerbs (Global Traditional)
GroupEuropean
Public Score StatusProvisional Strong
Primary Keywordbutterbur benefits
Butterbur (Petasites hybridus) — botanical
Butterbur (Petasites hybridus) — botanical close-up

Origin & History

Butterbur (Petasites hybridus) — origin
Natural habitat

Butterbur (Petasites hybridus) is a perennial herbaceous plant native to Europe and parts of Asia, with extracts primarily sourced from its rhizomes and roots. The plant material is processed via solvent extraction methods using isopropanol-glycerol mixtures followed by petroleum ether partitioning to yield extracts with 60-75% petasin content while removing toxic pyrrolizidine alkaloids.

Traditional uses are not specified in the available research. Modern pharmaceutical applications focus on PA-free extracts for potential spasmolytic and anti-inflammatory properties, with emphasis on removing toxic pyrrolizidine alkaloids for safe use.Traditional Medicine

Research Narrative (Provisional)

The available research lacks human clinical trials, RCTs, or meta-analyses for butterbur. All evidence comes from preclinical studies using PA-free extracts standardized to ≥15% petasins, showing effects on oxidative stress and NF-κB biomarkers, but without human trial data or PubMed PMIDs provided.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Butterbur (Petasites hybridus) root/rhizome contains negligible macronutrients in therapeutic extract form. Key bioactive compounds include: Sesquiterpenes (primary actives) — petasin and isopetasin collectively comprising 0.1–0.4% of raw root dry weight, concentrated to ≥15% petasins in standardized pharmaceutical extracts (e.g., Ze 339, Petadolex). Pyrrolizidine alkaloids (PAs) — present in raw plant at variable but potentially hepatotoxic levels (senkirkine, integerrimine); PA-free extracts are processed via CO2 supercritical extraction to reduce PAs to <0.1 ppm (below detection thresholds). Polyphenols — caffeic acid esters (e.g., petasitenine-related phenolics) present in trace amounts. Flavonoids — quercetin and kaempferol glycosides detected at low concentrations (<0.05% dry weight). Inulin-type fructans — present in raw rhizome as storage carbohydrates (~5–15% dry weight), though largely absent in concentrated extracts. Essential oils — trace volatile sesquiterpene fractions (<0.1%). Fiber content in raw root is moderate (~8–12% dry weight) but irrelevant in extract form. Vitamins and minerals are negligible and not therapeutically significant. Bioavailability notes: Petasin and isopetasin exhibit moderate oral bioavailability with Tmax ~1–2 hours post-ingestion of standardized extract; lipophilic nature of sesquiterpenes suggests absorption enhanced with dietary fat; PA-free supercritical CO2 extraction preserves petasin content while eliminating hepatotoxic alkaloids, making the standardized extract the only form with an established safety profile for human use.

Reported Mechanism (Provisional)

Mechanism of Action

Petasins, the primary bioactive compounds in butterbur, inhibit nuclear factor-κB (NF-κB) signaling pathways, reducing inflammatory mediator production. The standardized extracts also demonstrate spasmolytic activity by modulating calcium channels in smooth muscle tissue. Additionally, butterbur compounds reduce oxidative stress through antioxidant enzyme pathway activation.

Clinical Narrative (Provisional)

Current evidence for butterbur consists primarily of preclinical studies examining PA-free root extracts standardized to ≥15% petasins. Bulgarian standardized root extracts have shown measurable decreases in oxidative stress biomarkers via ELISA testing in laboratory models. NF-κB biomarker reduction has been documented in preliminary animal studies, though human clinical data remains limited. The evidence strength is considered preliminary pending larger controlled human trials.

Also Known As

Petasites hybridusEuropean butterburPurple butterburBog rhubarbBlatterdockCapdockinFlapperdockUmbrella plant

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.